2022
DOI: 10.1093/eurheartj/ehac661
|View full text |Cite
|
Sign up to set email alerts
|

Late outcomes of ST-elevation myocardial infarction treated by pharmaco-invasive or primary percutaneous coronary intervention

Abstract: Aims Pharmaco-invasive percutaneous coronary intervention (PI-PCI) is recommended for patients with ST-elevation myocardial infarction (STEMI)who are unable to undergo timely primary PCI (pPCI). The present study examined late outcomes after PI-PCI (successful reperfusion followed by scheduled PCI or failed reperfusion and rescue PCI)compared with timely and late pPCI (>120 min from first medical contact). Methods and results … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 11 publications
(5 citation statements)
references
References 39 publications
0
4
0
1
Order By: Relevance
“…29 Jamal et al found that patients who underwent late PPCI had higher mortality rates than those underwent a PI strategy. 30 In our study, compared with timely PPCI and late PPCI, scheduled PCI group was better in in-hospital mortality and MACCEs, which indicated early thrombolytic therapy may further shorten the myocardial ischemia time and reduce the ischemic events. The rate of heart failure was higher in the scheduled PCI, which may be caused by the worse condition of the scheduled PCI group, especially in the ratio of Killip II-IV class.…”
Section: Discussionmentioning
confidence: 49%
“…29 Jamal et al found that patients who underwent late PPCI had higher mortality rates than those underwent a PI strategy. 30 In our study, compared with timely PPCI and late PPCI, scheduled PCI group was better in in-hospital mortality and MACCEs, which indicated early thrombolytic therapy may further shorten the myocardial ischemia time and reduce the ischemic events. The rate of heart failure was higher in the scheduled PCI, which may be caused by the worse condition of the scheduled PCI group, especially in the ratio of Killip II-IV class.…”
Section: Discussionmentioning
confidence: 49%
“…7 In the study by Javeria et al, which included 2091 patients with STEMI within 12 h of symptom onset who underwent PCI during hospitalization at Liverpool Hospital (Sydney), the mortality rate during follow-up was higher in patients who underwent late PCI compared with those who underwent a PI-strategy; however, the rates of re-infarction, ischemic stroke, intracranial hemorrhage and major hemorrhage were similar between the two reperfusion strategies. 8 Doo Sun Sim and his team used the Korean acute myocardial infarction registry to compare two groups of patients who received either a PI-strategy defined as fibrinolysis followed by PCI (n = 708) versus the late PCI (n = 8878). In this study, patients who received a PI-strategy benefited from a shorter reperfusion time and a greater permeability of the culprit vessel compared with patients who had late PCI, but with a similar clinical outcome at 12 months.…”
Section: Discussionmentioning
confidence: 99%
“…In the study by Javeria et al, which included 2091 patients with STEMI within 12 h of symptom onset who underwent PCI during hospitalization at Liverpool Hospital (Sydney), the mortality rate during follow-up was higher in patients who underwent late PCI compared with those who underwent a PI-strategy; however, the rates of re-infarction, ischemic stroke, intracranial hemorrhage and major hemorrhage were similar between the two reperfusion strategies. 8 …”
Section: Discussionmentioning
confidence: 99%
“…Таким образом, у пациентов, которым было проведено позднее пЧКВ, смертность оказалась выше, чем у пациентов, перенесших фармакоинвазивное лечение. Несмотря на то, что трети пациентов, получивших ТЛТ, требуется спасительное ЧКВ, при ожидаемой задержке пЧКВ предпочтителен фармакоинвазивный подход, так как он обеспечивает лучшие исходы, чем позднее пЧКВ [20].…”
Section: актуальность фармакоинвазивной стратегии в лечении импStunclassified